SS-31
SS-31, also known as elamipretide, is a mitochondria-targeting tetrapeptide developed to influence mitochondrial function and cellular energy biology. It has been studied in both preclinical models and human clinical trials across several disease areas.
What Is SS-31?
SS-31 is a small peptide designed to concentrate within mitochondria—the structures responsible for producing much of the energy used by cells.
Research has focused on its interaction with cardiolipin, a phospholipid found in the inner mitochondrial membrane. Through this interaction, SS-31 has been studied for its effects on mitochondrial structure, electron transport, oxidative stress, and cellular energy production.
The pharmaceutical form of SS-31 is known as elamipretide. Research involving elamipretide provides considerably more human clinical data than many peptides commonly discussed in the wellness setting.
How SS-31 Is Being Studied
- Targets mitochondrial membranes
- Interacts with the mitochondrial phospholipid cardiolipin
- May influence electron-transport-chain efficiency
- Has been studied for effects on mitochondrial oxidative stress
- May help preserve mitochondrial structure and cellular bioenergetics
What Does the Research Show?
Elamipretide has progressed through human clinical development and has been evaluated in mitochondrial disease, cardiovascular disease, skeletal-muscle function, and other conditions involving impaired mitochondrial biology.
Clinical studies have demonstrated that the peptide reaches systemic circulation after subcutaneous administration and has provided substantial human safety and pharmacology data. Results for specific disease outcomes have varied by trial and patient population.
This body of research supports continued scientific interest in mitochondrial-targeted therapies, but it should not be interpreted as evidence that SS-31 provides anti-aging, performance, fat-loss, or general wellness benefits in healthy individuals.
Why Patients Ask About SS-31
Goals commonly discussed include:
- Cellular-energy and mitochondrial-health goals
- Exercise and recovery concerns
- Fatigue-related wellness goals
- Interest in healthy-aging research
- Broader metabolic and performance planning
These are discussion areas, not approved indications or guaranteed treatment outcomes.
What to Know
SS-31 and elamipretide should not automatically be treated as interchangeable products. Pharmaceutical clinical-trial data involve specific formulations and controlled manufacturing.
Evidence from disease-focused clinical trials does not establish effectiveness for general wellness, athletic performance, anti-aging, or other commonly promoted off-label goals.
A provider should review your health history, medications, treatment goals, available evidence, and alternative options before any therapy is considered.
Interested in SS-31?
Schedule a consultation to discuss your goals, current health, and available treatment options.